Mannose-6-Phosphate IGF-2 Receptor Activation for Memory Impairment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective methods to enhance memory retention and recovery from memory impairments, particularly in conditions such as neurodegenerative diseases and other pathological situations where memory loss occurs.
Innovation Solution
Administration of a therapeutically effective amount of an agonist or activator of the IGF-2 receptor, specifically mannose-6-phosphate (M6P) or its derivatives, to enhance memory and treat memory impairments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional memory treatment methods are used, then memory retention and recall are maintained at baseline levels, but effective enhancement of memory in pathological conditions is not achieved
Solution Approach 1:
The patent changes the chemical parameter by using M6P and its derivatives (such as phosphonate M6P, sulfonate M6P, and carboxylate M6P) instead of conventional treatments. These modified sugar molecules have altered chemical properties that enable them to effectively activate IGF-2 receptors, thereby improving memory retention and reducing memory impairment in pathological conditions
Solution Approach 2:
The patent introduces M6P and its derivatives as intermediary molecules that mediate between the administered compound and the IGF-2 receptor. These intermediaries bind to and activate the IGF-2 receptor, triggering downstream signaling pathways that enhance memory function without directly being the receptor itself
2Reliability
If M6P or its derivatives are administered to enhance memory, then memory retention and recall are significantly improved, but the complexity of the treatment composition increases
Solution Approach 1:
The patent simplifies the treatment composition by focusing on a core molecule (M6P) and its systematic derivatives that all share the same mechanism of action. By changing only specific chemical parameters (such as replacing phosphate with phosphonate, sulfonate, or carboxylate groups), the patent creates a series of related compounds that can be used interchangeably, reducing the complexity of developing and administering multiple different treatments
Data Source
AI summary
Provided are compositions and methods for memory enhancement, including recovery of memory impairment. The compositions and methods relate to mannose-6-phosphate and derivatives of mannose-6-phosphate. The methods relate to administration of M6P or derivatives thereof to individuals in whom memory enhancement is desired.